MXC Operations Update
Filed with ASX · · 4 pages · English
Story so far
Earlier from Argent Biopharma
- New Panax Acquisition Agreement Signed, Settlement Imminent
- First Major European Sales and Revenue for MGC Derma Range
- Cleansing Prospectus
- EU Registration Commenced for CBD Derma Product Sales
- September Quarter Activity and Cashflow Report
Later from Argent Biopharma
- European CPNP Approval Granted for Derma Products
- Commencement of Dermatological Clinical Trials
- Panax Acquisition Completed
- Medical Cannabis Clinical Study Commencing
- Cannabinoid Extraction Facility On Target Q2 Production
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma